<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="pmc-domain-id">82</journal-id><journal-id journal-id-type="pmc-domain">aac</journal-id><journal-id journal-id-type="publisher-id">ANTIMICROB AGENTS CHEMOTHER</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC89859</article-id><article-id pub-id-type="pmcid-ver">PMC89859.1</article-id><article-id pub-id-type="pmcaid">89859</article-id><article-id pub-id-type="pmcaiid">89859</article-id><article-id pub-id-type="pmid">10770766</article-id><article-id pub-id-type="doi">10.1128/aac.44.5.1302-1308.2000</article-id><article-id pub-id-type="publisher-id">0484</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Clinical Therapeutics</subject></subj-group></article-categories><title-group><article-title>Combinations of Artemisinin and Quinine for Uncomplicated Falciparum Malaria: Efficacy and Pharmacodynamics</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>de Vries</surname><given-names initials="PJ">Peter J.</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">1</xref><xref ref-type="author-notes" rid="FN150">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bich</surname><given-names initials="NN">Nguyen Ngoc</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Van Thien</surname><given-names initials="H">Huynh</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hung</surname><given-names initials="LN">Le Ngoc</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Anh</surname><given-names initials="TK">Trinh Kim</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kager</surname><given-names initials="PA">Piet A.</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heisterkamp</surname><given-names initials="SH">Siem H.</given-names></name><xref ref-type="aff" rid="N0x9656128.0x968ec88">4</xref></contrib></contrib-group><aff id="N0x9656128.0x968ec88"> Division of Infectious Diseases, Tropical Medicine and AIDS<sup>1</sup> and  Department of Clinical Epidemiology and Biostatistics,<sup>4</sup> Academic Medical Center, Amsterdam, The Netherlands, and  Tropical Diseases Clinical Research Center, Cho Ray Hospital, Ho Chi Minh City,<sup>2</sup> and  Lam Dong Provincial Hospital II, Bao Loc, Lam Dong Province,<sup>3</sup> Vietnam</aff><author-notes><fn id="FN150"><label>*</label><p>Corresponding author. Mailing address: Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center F4.217, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Phone: 31 20 5662170. Fax: 31 20 6972286. E-mail: <email>p.j.devries@amc.uva.nl</email>.</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2000</year></pub-date><volume>44</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">2484</issue-id><fpage>1302</fpage><lpage>1308</lpage><history><date date-type="received"><day>17</day><month>6</month><year>1999</year></date><date date-type="rev-request"><day>31</day><month>10</month><year>1999</year></date><date date-type="accepted"><day>9</day><month>2</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2000</year></date></event><event event-type="pmc-live"><date><day>24</day><month>09</month><year>2002</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-10-31 10:56:17.363"><day>31</day><month>10</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2000, American Society for Microbiology</copyright-statement><copyright-year>2000</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ac001302.pdf"/><abstract><p>Combinations of artemisinin and quinine for uncomplicated falciparum malaria were studied. A total of 268 patients were randomized to 7 days of quinine at 10 mg/kg of body weight three times a day (Q) or to artemisinin at 20 mg/kg of body weight followed by 3 (AQ3) or 5 (AQ5) days of quinine. Recrudescence rates were 16, 38, and 15% for the Q, AQ3, and AQ5 groups, respectively (<italic>P</italic> &lt; 0.001). Recrudescence was associated with shorter parasite clearance time (PCT) and longer treatment after the blood smear had become negative (eradication time). However, classification of patients to outcome&#8212;recrudescence or radical cure&#8212;was correct in only 77% of patients. The population kinetics of the parasitemia was estimated with nonlinear mixed-effect models. Several models were tested, but the best model was a monoexponential decline of the parasitemia in which the mean parasite elimination half-life was shorter after artemisinin (5.1 h; 95% confidence interval [CI], 4.9 to 5.2 h) than after quinine (8.0 h [95% CI, 7.5 to 8.3 h]). Attempts to simulate the initial increase of the parasitemia did not result in better models with a biologically plausible interpretation. Recrudescence was associated with slower parasite clearance and a higher simulated terminal parasitemia (<italic>P</italic><sub>term</sub>). The classification of patients to outcome groups based on <italic>P</italic><sub>term</sub> was correct in 78% of patients. The data suggest that parasite strains with reduced sensitivity to quinine are prevalent in Vietnam, with slower parasite clearance and consequent recrudescence. A single dose of artemisinin induces rapid parasite reduction and lowers the value of <italic>P</italic><sub>term</sub>, but to prevent recrudescence, this should be followed by quinine for at least 3 days after parasite clearance, or 5 days in total.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>